Topics: Products Liability - 1502 results

    Drug manufacturer Allergan recently settled a case for an undisclosed amount, which claimed Botox caused botulism in a 5-year-old child in Oklahoma County. The boy suffered from leukodystrophy, a progressively degenerative neurological disease. His doctor treated his spasticity with Botox. The complaint states that a few days after the child was injected with Botox, he was diagnosed with botulinum poisoning and was hospitalized, requiring a ventilator and feeding tube. More than a year after the Botox injections, the …

A drywall worker who built houses during the California housing boom in the 1970s, when asbestos was used in virtually every type of building material, has won a $27 million jury award for a cancer caused by the toxic substance. When he was still in high school in 1967, Michael Sutherland got a job as a drywaller and continued working on residential and office buildings in San Diego County for over 25 years. Sutherland would rush from job to job, …

  Millions of patients take selective serotonin reuptake inhibitors (SSRIs) for depression, anxiety and other disorders. One out of 10 people in the United States use  antidepressants, making them one of the most widely prescribed medications according to a 2011 National Center for Health Statistics report. In our news video, Lawyers.com Editorial Director Betsy Kim interviews attorney Harris Pogust, a partner at Pogust Braslow & Milrood in Conshohocken, Penn. He claims patients on SSRIs such as Celexa, Prozac, Paxil, Zoloft …

The U.S. Supreme Court today heard arguments in a case that will further refine to what extent the makers of generic pharmaceutical drugs can be sued in state court. In Bartlett v. Mutual Pharmaceuticals, the justices will decide if federal law that governs the design of generic drugs preempts state consumer protection laws in cases where the drugs injure patients. Karen Bartlett was blinded and suffered horrific skin problems in 2004, with two-thirds of her body becoming an open wound, …

A jury in California on Mar. 8 ordered DePuy Orthopaedics to pay over $8.3 million to a man who says the Johnson & Johnson subsidiary knowingly made and marketed a faulty hip replacement device.    Mixed Verdict In the trial, which began in January, Loren Kransky alleged that the DePuy Articular Surface Replacement (ASR) he received was defective and that the company failed to warn its users that the metal ball and socket could grind against each other and release …